The Hospital Universitario de la Princesa is a hospital located in the Lista neighborhood in Madrid, Spain, part of the hospital network of the Servicio Madrileño de Salud. It is one of the healthcare institutions associated to the Autonomous University of Madrid for the purpose of clinical internship.

There are 564 beds in Hospital Universitario de la Princesa.

During the past decade, Hospital Universitario de la Princesa conducted 297 clinical trials. In the 10-year time frame, 297 clinical trials started and 123 clinical trials were completed, i.e. on average, 41.4% percent of trials that started reached the finish line to date. In the past 5 years, 139 clinical trials started and 72 clinical trials were completed. i.e. 51.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario de la Princesa" #1 sponsor was "Pfizer" with 37 trials, followed by "PETHEMA Foundation" with 30 trials sponsored, "Celgene" with 27 trials sponsored, "Fundación de Investigación Biomédica - Hospital Universitario de La Princesa" with 19 trials sponsored and "Boehringer Ingelheim" with 19 trials sponsored. Other sponsors include 344 different institutions and companies that sponsored additional 204 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de la Princesa" #1 collaborator was "Eli Lilly and Company" with 8 trials as a collaborator, "Pfizer" with 8 trials as a collaborator, "Fundación de Investigación Biomédica - Hospital Universitario de La Princesa" with 7 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator and "Hoffmann-La Roche" with 6 trials as a collaborator. Other collaborators include 308 different institutions and companies that were collaborators in the rest 241 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de la Princesa" are "Multiple Myeloma" (30 trials), "Ulcerative Colitis" (16 trials), "Crohn Disease" (13 trials), "Breast Cancer" (12 trials) and "Crohn's Disease" (11 trials). Many other conditions were trialed in "Hospital Universitario de la Princesa" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de la Princesa" are "Drug" (337 trials), "Other" (52 trials), "Biological" (28 trials), "Device" (28 trials) and "Procedure" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (91 trials), "Dexamethasone" (18 trials), "Cyclophosphamide" (10 trials), "Prednisone" (10 trials) and "Lenalidomide" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de la Princesa" are 445 trials for "All" genders, 17 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are 129 active trials in "Hospital Universitario de la Princesa". 1 are not yet recruiting, 69 are recruiting, 57 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 266 completed trials in Hospital Universitario de la Princesa, 1 suspended trials, and 50 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de la Princesa, 16 "Phase 1" clinical trials were conducted, 101 "Phase 2" clinical trials and 190 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 50 trials, and there were also 33 trials that are defined as “Not Applicable".

Hospital Universitario de la Princesa has several departments that took part in Clinical trials: "Hospital Universitario de la Princesa; Servicio de Neurologia" - 12 trials, "Hospital Universitario de la Princesa; Servicio de Hematologia" - 7 trials, "Hospital Universitario de la Princesa; Servicio de Oncologia" - 4 trials, "Hospital Universitario La Princesa; Servicio de Neumologia" - 3 trials, "Clinical Pharmacology Department. Hospital Universitario de La Princesa" - 2 trials, "Hospital Universitario de la Princesa; Servicio de Reumatologia" - 2 trials